Ensuring Viral Vector Supply For Gene Therapies
Source: MilliporeSigma
The rapid success of gene therapies also brings with it a number of challenges, the most significant being ensuring a sufficient viral vector supply, despite shortened development timelines.
This infographic demonstrates how cells grown in suspension are much better suited for large-scale production of viral vectors, what to consider in order to successfully scale-up your viral vector production, including the challenges faced in upstream upscaling, and a specific solution we’ve developed to help you address these challenges.
Labiotech UG, All Rights Reserved. Learn more at https://www.labiotech.eu/infographics/ensuring-viral-vector-supply-gene-therapies/
VIEW THE INFOGRAPHIC!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Cell & Gene? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more